ArticleInternational journal of nanomedicine2024

Exenatide-Modified Deferoxamine-Based Nanoparticles Ameliorates Neurological Deficits in Parkinson's Disease Mice.

Yiming Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.